Policy Priorities ARM influences policy to ensure our systems can accommodate the growing pipeline of cell and gene therapies Jump to: Policy Priorities Comment Letters Advance a fit-for-purpose EU Joint Clinical Assessment methodology The EU Joint Clinical Assessment (JCA), which will begin in January 2025, will significantly impact patient access to cell and gene therapies […] More @Wikipedia
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.